Pages that link to "Q45227725"
Jump to navigation
Jump to search
The following pages link to Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism. (Q45227725):
Displaying 50 items.
- Platelet lipidomics: modern day perspective on lipid discovery and characterization in platelets (Q26998976) (← links)
- An Update of Microsomal Prostaglandin E Synthase-1 and PGE2 Receptors in Cardiovascular Health and Diseases (Q28067884) (← links)
- Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease (Q28218124) (← links)
- Cardiovascular risk, hypertension, and NSAIDs (Q28298198) (← links)
- Increased aortic atherosclerotic plaque development in female apolipoprotein E-null mice is associated with elevated thromboxane A2 and decreased prostacyclin production. (Q30423459) (← links)
- Relative thromboembolic risks associated with COX-2 inhibitors (Q30437125) (← links)
- Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function (Q30477135) (← links)
- Oxidative risk for atherothrombotic cardiovascular disease (Q33554184) (← links)
- COX-2 protects against atherosclerosis independently of local vascular prostacyclin: identification of COX-2 associated pathways implicate Rgl1 and lymphocyte networks (Q33699097) (← links)
- Thromboxane and the thromboxane receptor in cardiovascular disease (Q33899567) (← links)
- Rationale, design and population baseline characteristics of the PERFORM vascular project: an ancillary study of the Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF [...] (Q33920331) (← links)
- Targeted deletions of cyclooxygenase-2 and atherogenesis in mice. (Q34019117) (← links)
- Impact of vascular thromboxane prostanoid receptor activation on hemostasis, thrombosis, oxidative stress, and inflammation. (Q34389439) (← links)
- Adventures in vascular biology: a tale of two mediators (Q34515584) (← links)
- A ceramide analog inhibits cPLA(2) activity and consequent PGE(2) formation in LPS-stimulated macrophages. (Q34520481) (← links)
- Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis. (Q35029268) (← links)
- Antagonism of the antithrombotic and anti-atherosclerotic actions of aspirin by rofecoxib in the cholesterol-fed rabbit (Q35287418) (← links)
- Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy (Q35373624) (← links)
- Heterodimerization of the alpha and beta isoforms of the human thromboxane receptor enhances isoprostane signaling (Q35579014) (← links)
- Cardiovascular biology of microsomal prostaglandin E synthase-1. (Q35607129) (← links)
- Effect of cyclooxygenase inhibition on cholesterol efflux proteins and atheromatous foam cell transformation in THP-1 human macrophages: a possible mechanism for increased cardiovascular risk. (Q35769055) (← links)
- Cyclooxygenase-2 inhibitors and coronary occlusion--exploring dose-response relationships (Q35827780) (← links)
- Nitric oxide deficiency promotes vascular side effects of cyclooxygenase inhibitors (Q35848746) (← links)
- Disruption of the 5-lipoxygenase pathway attenuates atherogenesis consequent to COX-2 deletion in mice. (Q35921866) (← links)
- Elucidating mechanisms of drug-induced toxicity. (Q36111915) (← links)
- Celecoxib and cardiovascular risks (Q36299969) (← links)
- Cardiovascular risk with cyclooxygenase inhibitors: general problem with substance specific differences? (Q36439704) (← links)
- Nicotinic acid and DP1 blockade: studies in mouse models of atherosclerosis (Q36462055) (← links)
- Therapy Insight: managing cardiovascular risk in patients with rheumatoid arthritis (Q36577503) (← links)
- Drug-induced immunomodulation to affect the development and progression of atherosclerosis: a new opportunity? (Q36752124) (← links)
- Developing strategies to link basic cardiovascular sciences with clinical drug development: another opportunity for translational sciences (Q36773491) (← links)
- Biased suppression of TP homodimerization and signaling through disruption of a TM GxxxGxxxL helical interaction motif (Q36822598) (← links)
- High-dose, but not low-dose, aspirin impairs anticontractile effect of ticagrelor following ADP stimulation in rat tail artery smooth muscle cells (Q36948503) (← links)
- An eicosanoid-centric view of atherothrombotic risk factors (Q36952174) (← links)
- Macrophage EP4 deficiency increases apoptosis and suppresses early atherosclerosis (Q37039326) (← links)
- Cardiovascular risk, hypertension, and NSAIDs. (Q37049698) (← links)
- Cyclooxygenase products and atherosclerosis (Q37071164) (← links)
- Microsomal prostaglandin E synthase-1 inhibition in cardiovascular inflammatory disease (Q37138028) (← links)
- Cyclooxygenase inhibition improves endothelial vasomotor dysfunction of visceral adipose arterioles in human obesity. (Q37154250) (← links)
- Platelet activation, and antiplatelet targets and agents: current and novel strategies. (Q37235603) (← links)
- Prostanoids in health and disease (Q37354582) (← links)
- Prostacyclin receptor/thromboxane receptor interactions and cellular responses in human atherothrombotic disease (Q37441291) (← links)
- Platelet interactions as therapeutic targets for prevention of atherothrombosis (Q37486621) (← links)
- Platelet function and Isoprostane biology. Should isoprostanes be the newest member of the orphan-ligand family? (Q37725138) (← links)
- Pathophysiology of cyclooxygenases in cardiovascular homeostasis (Q37736991) (← links)
- Antiplatelet drugs--do we need new options? With a reappraisal of direct thromboxane inhibitors (Q37738868) (← links)
- TP receptor activation and inhibition in atherothrombosis: the paradigm of diabetes mellitus. (Q37782025) (← links)
- Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke (Q37995534) (← links)
- Clinical implications of platelet-vessel interaction (Q38070127) (← links)
- Molecular biology of atherosclerosis (Q38125279) (← links)